In such cases, the characteristic pattern of platelet count decline following heparin administration, the temporal relationship between heparin exposure and thrombocytopenia, and the detection of anti‐PF4/heparin antibodies are crucial for distinguishing HITT from recurrent thrombotic events due to thrombophilia alone. The gene discussed is PF4; the disease is Rare hereditary thrombophilia.